AstraZeneca To Buy Rare-Disease Specialist Drugmaker Alexion For $39 Billion

AstraZeneca plc AZNhas announced it will buy Alexion Pharmaceuticals, Inc. ALXN, a Boston-based drugmaker, for $39 billion.

What Happened: British pharmaceutical company AstraZeneca and Boston-based Alexion said this morning that their boards unanimously approved the deal. It is expected to close in the third quarter of next year. Alexion shareholders will own about 15% of the new company. The shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares for each Alexion share, or about $175 a share, the companies said.

Why It Matters: The companies said this will make AstraZeneca stronger in immunology and in making drugs to fight rare diseases. The British drugmaker is among the companies vying to get its COVID-19 vaccine to market, though it now has been beaten to the punch by Pfizer Inc. PFE and its German partner BioNTech SE – ADR BNTX.

Paul Singer's activist investor hedge fund Elliott Management Corp. this year has been pushing Alexion to sell, criticizing Alexion's earlier acquisition of San Francisco-based Portola.

Price Action: AstraZeneca's shares closed out the week at $54.27, up 0.24%. Alexion closed the week at $120.98, up 1.04%. Its shares are up 7.57% this calendar year.

Posted In: BiotechM&ANewsGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.